Fairey William

Track

Insider profile

Performance

Overall performance
0.6
Performance over holding periods
0.6
30 days 90 days 120 days
Average return -9% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Fairey William's trades of Ascendis Pharma A/S's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
423.20
Quantity 50,787
Value US$2,846,643
Transaction date
Sale
Price
249.05
Quantity 45,516 +34.7%
Value US$1,267,107
Transaction date
Proposed sale
Price
373.73
Quantity 29,866
Value US$3,775,938
Transaction date
Proposed sale
Price
152.12
Quantity 1,006
Value US$153,037
US MyoKardia Inc (MYOK)
Transaction date
Sale
Price
68.04
Quantity 2,899 -35.7%
Value US$197,248
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-02 2026-03-02
PrS Proposed sale
50,787
423.20
US$2,846,643 		50,787 423.20 US$2,846,643
2025-06-13 2025-06-11
S Sale
45,516 +34.7%
249.05
US$1,267,107 		45,516 +34.7% 249.05 US$1,267,107
2025-06-11 2025-06-11
PrS Proposed sale
29,866
373.73
US$3,775,938 		29,866 373.73 US$3,775,938
2025-03-04 2025-03-04
PrS Proposed sale
1,006
152.12
US$153,037 		1,006 152.12 US$153,037
2024-03-05 2024-03-05
PrS Proposed sale
200
147.99
US$29,598 		200 147.99 US$29,598
2020-02-03 2020-02-01
US MyoKardia Inc (MYOK)
S Sale
2,899 -35.7%
68.04
US$197,248 		2,899 -35.7% 68.04 US$197,248